GlassScriptPhysician profile
Giovanni Hernandez
NPI 1023028412
$4,139.76
in general payments reported to CMS, 2019-2025
24 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $512 · 2021: $1,075 · 2022: $1,103 · 2023: $219 · 2024: $251 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,027.29 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $735.53 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $425.74 | 2019-2024 | Mounjaro |
| Abbvie INC. | $175.24 | 2019-2025 | |
| Pfizer INC. | $87.96 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $79.09 | 2019-2022 | |
| Exact Sciences Corporation | $67.52 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Esperion Therapeutics, INC. | $54.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.86 | 2022 | |
| Daiichi Sankyo INC. | $50.92 | 2022 | |
| Allergan, INC. | $49.93 | 2019-2020 | |
| Amarin Pharma, INC. | $35.86 | 2020-2021 | |
| Organogenesis INC. | $30.61 | 2022 | |
| Merck Sharp & Dohme LLC | $25.28 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orapharma, A Division of Bausch Health US, LLC | $23.71 | 2022 | |
| Amgen INC. | $19.46 | 2022 | |
| Glaxosmithkline, LLC. | $18.85 | 2020 | |
| Abbott Laboratories | $18.44 | 2022 | |
| Antares Pharma, INC. | $17.57 | 2022 | |
| Currax Pharmaceuticals LLC | $14.84 | 2020 | |
| Hologic Sales and Service, LLC | $14.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.70 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giovanni Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.